Market Highlights: Structure Therapeutics Inc ADR (GPCR) Ends on a Low Note at 52.91

In the journey to outperform the market, investors delve into the art of stock selection. Choosing the right stocks can be a powerful driver for wealth accumulation.

3 Tiny Stocks Primed to Explode The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.

We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.

Click here for full details and to join for free

The price of Structure Therapeutics Inc ADR (NASDAQ: GPCR) closed at $52.91 in the last session, down -0.30% from day before closing price of $53.07. In other words, the price has decreased by -$0.30 from its previous closing price. On the day, 1.22 million shares were traded. GPCR stock price reached its highest trading level at $53.98 during the session, while it also had its lowest trading level at $52.14.


We take a closer look at GPCR’s different ratios to gain a better understanding of the stock. For the most recent quarter (mrq), Quick Ratio is recorded 19.05 and its Current Ratio is at 19.05. In the meantime, Its Debt-to-Equity ratio is 0.01 whereas as Long-Term Debt/Eq ratio is at 0.01.

Upgrades & Downgrades

In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, JP Morgan on May 21, 2024, initiated with a Overweight rating and assigned the stock a target price of $65.

On April 09, 2024, Cantor Fitzgerald started tracking the stock assigning a Overweight rating and target price of $65.

On October 19, 2023, JMP Securities started tracking the stock assigning a Mkt Outperform rating and target price of $90.JMP Securities initiated its Mkt Outperform rating on October 19, 2023, with a $90 target price.

Valuation Measures:

Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, GPCR now has a Market Capitalization of 3018414848 and an Enterprise Value of 6968846848.

Stock Price History:

Over the past 52 weeks, GPCR has reached a high of $75.02, while it has fallen to a 52-week low of $25.57. The 50-Day Moving Average of the stock is 33.16%, while the 200-Day Moving Average is calculated to be 17.68%.

Shares Statistics:

According to the various share statistics, GPCR traded on average about 896.90K shares per day over the past 3-months and 2737230 shares per day over the past 10 days. A total of 46.41M shares are outstanding, with a floating share count of 41.85M. Insiders hold about 10.24% of the company’s shares, while institutions hold 85.85% stake in the company. Shares short for GPCR as of 1715731200 were 4112192 with a Short Ratio of 4.58, compared to 1713139200 on 4114099. Therefore, it implies a Short% of Shares Outstanding of 4112192 and a Short% of Float of 10.93.

Earnings Estimates

Currently, 7.0 analysts are dedicated to thoroughly evaluating and rating the performance of Structure Therapeutics Inc ADR (GPCR) in the stock market.On average, analysts expect EPS of -$0.23 for the current quarter, with a high estimate of -$0.2 and a low estimate of -$0.25, while EPS last year was -$0.6. The consensus estimate for the next quarter is -$0.24, with high estimates of -$0.21 and low estimates of -$0.29.

Analysts are recommending an EPS of between -$0.83 and -$1.1 for the fiscal current year, implying an average EPS of -$0.92. EPS for the following year is -$0.81, with 7.0 analysts recommending between $2.47 and -$1.6.

Most Popular